Cargando…
Genetic polymorphisms in lung disease: bandwagon or breakthrough?
The study of genetic polymorphisms has touched every aspect of pulmonary and critical care medicine. We review recent progress made using genetic polymorphisms to define pathophysiology, to identify persons at risk for pulmonary disease and to predict treatment response. Several pitfalls are commonl...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107844/ https://www.ncbi.nlm.nih.gov/pubmed/11980584 http://dx.doi.org/10.1186/rr164 |
_version_ | 1782120219893825536 |
---|---|
author | Iannuzzi, Michael C Maliarik, Mary Rybicki, Benjamin |
author_facet | Iannuzzi, Michael C Maliarik, Mary Rybicki, Benjamin |
author_sort | Iannuzzi, Michael C |
collection | PubMed |
description | The study of genetic polymorphisms has touched every aspect of pulmonary and critical care medicine. We review recent progress made using genetic polymorphisms to define pathophysiology, to identify persons at risk for pulmonary disease and to predict treatment response. Several pitfalls are commonly encountered in studying genetic polymorphisms, and this article points out criteria that should be applied to design high-quality genetic polymorphism studies. |
format | Text |
id | pubmed-107844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-1078442002-05-09 Genetic polymorphisms in lung disease: bandwagon or breakthrough? Iannuzzi, Michael C Maliarik, Mary Rybicki, Benjamin Respir Res Review The study of genetic polymorphisms has touched every aspect of pulmonary and critical care medicine. We review recent progress made using genetic polymorphisms to define pathophysiology, to identify persons at risk for pulmonary disease and to predict treatment response. Several pitfalls are commonly encountered in studying genetic polymorphisms, and this article points out criteria that should be applied to design high-quality genetic polymorphism studies. BioMed Central 2002 2002-02-19 /pmc/articles/PMC107844/ /pubmed/11980584 http://dx.doi.org/10.1186/rr164 Text en Copyright © 2002 BioMed Central Ltd |
spellingShingle | Review Iannuzzi, Michael C Maliarik, Mary Rybicki, Benjamin Genetic polymorphisms in lung disease: bandwagon or breakthrough? |
title | Genetic polymorphisms in lung disease: bandwagon or breakthrough? |
title_full | Genetic polymorphisms in lung disease: bandwagon or breakthrough? |
title_fullStr | Genetic polymorphisms in lung disease: bandwagon or breakthrough? |
title_full_unstemmed | Genetic polymorphisms in lung disease: bandwagon or breakthrough? |
title_short | Genetic polymorphisms in lung disease: bandwagon or breakthrough? |
title_sort | genetic polymorphisms in lung disease: bandwagon or breakthrough? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC107844/ https://www.ncbi.nlm.nih.gov/pubmed/11980584 http://dx.doi.org/10.1186/rr164 |
work_keys_str_mv | AT iannuzzimichaelc geneticpolymorphismsinlungdiseasebandwagonorbreakthrough AT maliarikmary geneticpolymorphismsinlungdiseasebandwagonorbreakthrough AT rybickibenjamin geneticpolymorphismsinlungdiseasebandwagonorbreakthrough |